RALEIGH, N.C., Aug. 22, 2011 /PRNewswire/ — PRA, a
leading Clinical Research Organization, recently opened a new
office in Bucharest, Romania to further strengthen our coverage of
the Balkan region’s burgeoning markets. The Bucharest office will
also support projects in the neighboring Republic of Moldova.
Since 2006, when PRA began conducting clinical trials in
Romania, the PRA staff has steadily increased and now includes both
product registration and early phase professionals. The number of
studies initiated by PRA in this region has more than doubled over
the last two years.
“By being based in the Balkan region’s key business and life
sciences hub, the Bucharest staff has convenient access to top
universities, academic research sites, and most of the country’s
major hospitals,” said Ludger Langer, PRA’s Vice President of
Clinical Operations in Europe, Asia-Pacific and Africa.
The Bucharest location is the 12th office PRA has opened
worldwide since 2009, demonstrating our commitment to meeting our
clients’ diverse needs in a dynamic clinical trials
environment.
About PRA
PRA is transforming clinical trials through our people,
innovation and transparency. PRA provides personalized service
customized to the unique requirements of each study. We support our
global reach and innovative approach through flexible and reliable
service, delivered by skilled employees dedicated to ensuring that
sponsors achieve their long-term goals.
We serve our clients across all phases of pharmaceutical and
biotech drug development by combining therapeutic and operational
expertise with local knowledge. Offering services in 80+ countries
and serving sponsors for 30+ years, we have amassed a level of
expertise that has enabled us to work on a variety of compounds,
ranging from niche treatments and therapies to blockbuster drugs.
But at PRA, we are looking to the future, not the past. Our
increasingly forward-thinking approa
‘/>”/>